These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 35001897)

  • 1. Self-Reported Visual Complaints in People with Parkinson's Disease: A Systematic Review.
    van der Lijn I; de Haan GA; Huizinga F; van der Feen FE; Rutgers AWF; Stellingwerf C; van Laar T; Heutink J
    J Parkinsons Dis; 2022; 12(3):785-806. PubMed ID: 35001897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and nature of self-reported visual complaints in people with Parkinson's disease-Outcome of the Screening Visual Complaints questionnaire.
    van der Lijn I; de Haan GA; van der Feen FE; Huizinga F; Stellingwerf C; van Laar T; Heutink J
    PLoS One; 2023; 18(4):e0283122. PubMed ID: 37014842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual complaints and visual hallucinations in Parkinson's disease.
    Urwyler P; Nef T; Killen A; Collerton D; Thomas A; Burn D; McKeith I; Mosimann UP
    Parkinsonism Relat Disord; 2014 Mar; 20(3):318-22. PubMed ID: 24405755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review and meta-analysis of clinical effectiveness of self-management interventions in Parkinson's disease.
    Pigott JS; Kane EJ; Ambler G; Walters K; Schrag A
    BMC Geriatr; 2022 Jan; 22(1):45. PubMed ID: 35016613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards seeing the visual impairments in Parkinson's disease: protocol for a multicentre observational, cross-sectional study.
    Borm CDJM; Werkmann M; Visser F; Peball M; Putz D; Seppi K; Poewe W; Notting IC; Vlaar A; Theelen T; Hoyng C; Bloem BR; de Vries NM
    BMC Neurol; 2019 Jun; 19(1):141. PubMed ID: 31238904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Undetected ophthalmological disorders in Parkinson's disease.
    Borm CDJM; Werkmann M; de Graaf D; Visser F; Hofer A; Peball M; Smilowska K; Putz D; Seppi K; Poewe W; Hoyng C; Bloem BR; Theelen T; de Vries NM
    J Neurol; 2022 Jul; 269(7):3821-3832. PubMed ID: 35262759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ophthalmologic features of Parkinson's disease.
    Biousse V; Skibell BC; Watts RL; Loupe DN; Drews-Botsch C; Newman NJ
    Neurology; 2004 Jan; 62(2):177-80. PubMed ID: 14745050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life in Parkinson's disease: A systematic review and meta-analysis of comparative studies.
    Zhao N; Yang Y; Zhang L; Zhang Q; Balbuena L; Ungvari GS; Zang YF; Xiang YT
    CNS Neurosci Ther; 2021 Mar; 27(3):270-279. PubMed ID: 33372386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double vision in Parkinson's Disease: a systematic review.
    Śmiłowska K; Wowra B; Sławek J
    Neurol Neurochir Pol; 2020; 54(6):502-507. PubMed ID: 33300115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of pramipexole on quality of life in patients with Parkinson's disease: a systematic review and meta-analysis.
    Li T; Zou S; Zhang Z; Liu M; Liang Z
    BMC Neurol; 2022 Aug; 22(1):320. PubMed ID: 36008796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Visual Impairment on Vision-Related Quality of Life in Parkinson's Disease.
    Pengo M; Murueta-Goyena A; Teijeira-Portas S; Acera M; Del Pino R; Sáez-Atxukarro O; Diez-Cirarda M; Tijero B; Fernández-Valle T; Gómez Esteban JC; Gabilondo I
    J Parkinsons Dis; 2022; 12(5):1633-1643. PubMed ID: 35466953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Screening Visual Complaints questionnaire (SVCq) in people with Parkinson's disease-Confirmatory factor analysis and advice for its use in clinical practice.
    van der Lijn I; de Haan GA; van der Feen FE; Huizinga F; Fuermaier ABM; van Laar T; Heutink J
    PLoS One; 2022; 17(9):e0272559. PubMed ID: 36103511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Convergence Insufficiency-Type Symptomatology in Parkinson's Disease.
    Law C; Chriqui E; Kergoat MJ; Leclerc BS; Panisset M; Irving EL; Postuma RB; Chouinard S; Kergoat H
    Can J Neurol Sci; 2017 Sep; 44(5):562-566. PubMed ID: 28862105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-reported visual dysfunction in Parkinson disease: the Survey of Health, Ageing and Retirement in Europe.
    Hamedani AG; Willis AW
    Eur J Neurol; 2020 Mar; 27(3):484-489. PubMed ID: 31571317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Visual impairment in Parkinson’s disease].
    Dalbro SEJ; Kerty E
    Tidsskr Nor Laegeforen; 2024 May; 144(6):. PubMed ID: 38747667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of depression and anxiety via patient-assessed tremor severity, not physician-reported motor symptom severity, in patients with Parkinson's disease or essential tremor who have undergone deep brain stimulation.
    Achey RL; Yamamoto E; Sexton D; Hammer C; Lee BS; Butler RS; Thompson NR; Nagel SJ; Machado AG; Lobel DA
    J Neurosurg; 2018 Dec; 129(6):1562-1571. PubMed ID: 29473781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions for fatigue in Parkinson's disease.
    Elbers RG; Verhoef J; van Wegen EE; Berendse HW; Kwakkel G
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD010925. PubMed ID: 26447539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual Dysfunction and Occupational Performance in Persons With Parkinson's Disease.
    Tester NJ; Liu CJ; Shin YC; Shukla AW
    Am J Occup Ther; 2023 Nov; 77(6):. PubMed ID: 38048262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognizing visual complaints in people with multiple sclerosis: Prevalence, nature and associations with key characteristics of MS.
    van der Feen FE; de Haan GA; van der Lijn I; Huizinga F; Meilof JF; Heersema DJ; Heutink J
    Mult Scler Relat Disord; 2022 Jan; 57():103429. PubMed ID: 34863058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.